The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
May. 24, 2016

Filed:

Oct. 05, 2012
Applicant:

Keio University, Tokyo, JP;

Inventors:

Shigeto Shimmura, Tokyo, JP;

Shin Hatou, Tokyo, JP;

Kazuo Tsubota, Tokyo, JP;

Satoru Yoshida, Tokyo, JP;

Assignee:

Keio University, Tokyo, JP;

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C12N 5/079 (2010.01); A61L 27/38 (2006.01); C12N 5/071 (2010.01); A61K 35/00 (2006.01);
U.S. Cl.
CPC ...
C12N 5/0621 (2013.01); A61L 27/3808 (2013.01); A61L 27/3895 (2013.01); C12N 5/069 (2013.01); A61K 35/00 (2013.01); A61L 2430/16 (2013.01); C12N 2501/11 (2013.01); C12N 2501/115 (2013.01); C12N 2501/15 (2013.01); C12N 2501/235 (2013.01); C12N 2501/33 (2013.01); C12N 2501/385 (2013.01); C12N 2501/727 (2013.01); C12N 2501/999 (2013.01); C12N 2506/08 (2013.01); C12N 2506/09 (2013.01); C12N 2506/45 (2013.01); C12N 2533/54 (2013.01);
Abstract

The invention provides a method of efficiently producing corneal endothelial cells, particularly from corneal stroma or iPS cell-derived neural crest stem cells, a method of producing corneal endothelial cells stably in a large amount by inducing more efficient differentiation of stem cells into corneal endothelial cells, and a medicament containing corneal endothelial cells. The method of inducing differentiation of stem cells into corneal endothelial cells includes a step of culturing the stem cells in a differentiation induction medium containing a GSK3 inhibitor (preferably a GSK3β inhibitor) and retinoic acid, with the differentiation induction medium preferably further containing one or more of TGFb2, insulin, a ROCK inhibitor, and the like.


Find Patent Forward Citations

Loading…